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The mitochondrial pyruvate dehydrogenase complex (mtPDC) is regulated by reversible
seryl-phosphorylation of the E1α subunit by a dedicated, intrinsic kinase. The
phospho-complex is reactivated when dephosphorylated by an intrinsic PP2C-type
protein phosphatase. Both the position of the phosphorylated Ser-residue and the
sequences of the flanking amino acids are highly conserved. We have used the synthetic
peptide-based kinase client (KiC) assay plus recombinant pyruvate dehydrogenase E1α
and E1α-kinase to perform “scanning mutagenesis” of the residues flanking the site of
phosphorylation. Consistent with the results from “phylogenetic analysis” of the flanking
sequences, the direct peptide-based kinase assays tolerated very few changes. Even
conservative changes such as Leu, Ile, or Val for Met, or Glu for Asp, gave very marked
reductions in phosphorylation. Overall the results indicate that regulation of the mtPDC by
reversible phosphorylation is an extreme example of multiple, interdependent instances
of co-evolution.
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INTRODUCTION
The mitochondrial pyruvate dehydrogenase complex (mtPDC)
is a 10MDa nanomachine consisting of multiple copies of
three central enzymes (Mooney et al., 2002). Pyruvate dehy-
drogenase (E1) catalyzes the oxidative decarboxylation of
pyruvate using thiamine-pyrophosphate as a cofactor, followed
by the reductive-acetylation of lipoyl moieties covalently
linked to dihydrolipoamide acetyltransferase (E2) which
transfers the acetyl-group to CoASH, releasing acetyl-CoA
as a product. Dihydrolipoyl dehydrogenase (E3) contains
a FAD cofactor, and completes the reaction cycle by re-
oxidizing the lipoyl groups of E2, using NAD+ as the electron
acceptor.
The core of mtPDC is a pentagonal dodecahedron consist-
ing of 60 E2 polypeptides arranged with icosahedral symmetry
(Reed, 1974; Thelen et al., 1999; Smolle et al., 2006). The E1
and E3 enzymes are non-covalently associated with the E2 core
structures. The quaternary structure of mtPDC E1 is an α2β2-
heterotetramer (Fries et al., 2003). Overall, mtPDCs are very
large structures with diameters of up to 50 nm. They can be
easily visualized in vitro by either negative staining transmis-
sion electron microscopy (Stoops et al., 1992) or cryo-electron
microscopy (Milne et al., 2006). The complex molecular archi-
tecture allows enhanced catalytic efficiency, achieved by a combi-
nation of active-site coupling and substrate channeling (Perham,
2000; Perham et al., 2002).
The mtPDC occupies a strategic and overlapping position in
catabolic and anabolic metabolism, and activity is regulated by
multiple posttranslational mechanisms including product and
metabolite inhibition, and reversible multi-site phosphorylation
catalyzed by intrinsic kinase (PDK) and phosphatase (PDP)
components (Mooney et al., 2002; Tovar-Méndez et al., 2003).
Phosphorylation of the E1α subunit by PDK inactivates the PDC,
which is then reactivated by PDP-catalyzed dephosphorylation.
The relative position of the Ser residue that comprises regulatory
phosphorylation site 1 (Yeaman et al., 1978) plus the immediate
flanking residues are conserved in all mtPDC sequences. Sites 2
and 3 have been defined only in mammalian sequences, and it is
believed that Saccharomyces cerevisiae is phosphorylated only at
site 1 (Gruhler et al., 2005; Krause-Buchholz et al., 2006).
There have been a very limited number of studies aimed at
characterizing the effects of changes to amino acids flanking site
1 (Sugden et al., 1979; Mullinax et al., 1985; Hirani et al., 2011).
Herein we report results from analysis of a series of systematic
changes to Ser-flanking residues on phosphorylation of site 1 by
PDK, using the synthetic peptide-based kinase client (KiC) assay
(Huang et al., 2010).
METHODS ANDMATERIALS
SYNTHETIC PEPTIDES
A library of YHGHSMSDPGSTYR-variants consisting of 59
14-mer peptides was synthesized by the Sigma Chemical Co.
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(PEPscreen, St. Louis, MO, USA). The sequences are listed in
Table A1. Stock solutions were prepared by dissolving the pep-
tides in 80% (v/v) dimethylformamide in H2O to a final concen-
tration of 8mM. Peptides (Table A1) were further diluted from
the stock solutions into the assays.
ASSAY OF PDC E1α-KINASE ACTIVITY
Recombinant His6-AtPDK was prepared as described previously
(Tovar-Méndez et al., 2005). The synthetic peptide-based KiC
assay (Huang et al., 2010) was used with minor modifications.
Assays were conducted for 1 h at 37◦C, with 500 rpm agitation.
The assay volume was 40μL, and peptides were tested at a final
concentration of 20μM. After assay, samples were immediately
frozen and freeze-dried.
Prior to MS analysis, freeze dried-samples were dissolved by
adding 40μL of 0.1% formic acid. Half of each sample was added
to a 96-well plate which was then placed onto a 10◦C cooled
auto-sampler. Ten microliter of each sample was analyzed using
a Finnigan Surveyor liquid chromatography (LC) system cou-
pled with an LTQ Orbitrap XL ETD mass spectrometer (Thermo
Fisher, San Jose, CA). After injection, peptides were bound to a
C8 Captrap (Michrom Bioresources, Auburn, CA, USA), eluted
with a gradient of 1 to 30% acetonitrile (ACN) in 0.1% formic
acid over a period of 15min, and then separated using a “Magic
C18” (200 Å, 5μ bead, Michrom Bioresources) fused silica col-
umn (10 cm× 150μ, Polymicro Technologies, Phoenix, AZ). The
C8 Captrap and fused silica column were purged with two spikes
of 80% ACN over a period of 6min, before being re-equilibrated
to 0.1% formic acid. Prior to MS analysis, the C18-fused silica
column was pre-equilibrated with a gradient of 100–0% ACN
in 0.1% formic acid to rid the matrix of any contaminating
ions. Instrument settings were similar to those used previously
(Huang et al., 2010). Precursor mass values were scanned with the
analyzer set to FTMS: mass range, normal; resolution, 100,000;
scan type, full; polarity, positive; data type, centroid; and a scan
range of 300–2000m/z. Nanospray ionization source settings
were: spray voltage, 2.1 kV; capillary temp, 250◦C; capillary volt-
age, 36 V, and tube lens, 90V. The four most abundant ions
from the precursor scan were selected for data-dependent acqui-
sition using the ion trap-analyzer, normal mass range, normal
scan rate, centroid data type, and a minimum signal threshold
of 500 counts. Collision induced dissociation activation settings
included: isolation width, 2.0m/z; normalized collision energy,
35; and activation time, 30ms. Dynamic exclusion was disabled.
The multi-stage activation acquisition mode was enabled with
neutral loss masses of −24.5, −32.7, −49.0, and −98.0.
BIOINFORMATIC ANALYSIS
The MS data were exported, processed, and compared with a
decoy database consisting of the random complement of the
sequences comprising the peptide library, using the SEQUEST
algorithm (Proteome Discoverer 1.0, Thermo Fisher). The search
parameter settings have been previously described (Huang et al.,
2010). Identifications were evaluated using the XCorr versus
charge state function of Proteome Discoverer, and peptide identi-
ties with a score of >13.01 (a probability of 0.05) were accepted.
The XCorr values for each charge state were set to default,
and no decoy hits were allowed. Spectra that passed this fil-
tering were exported to PhosSite (in-house software, available
for download at digbio.missouri.edu/p3db/tools) to assign spe-
cific sites of phosphorylation. For final validation, each spectrum
was inspected manually, and accepted only when the phospho-
peptide had the highest XCorr value, site-determining fragment
ions allowed unambiguous localization of the phosphorylation
site, and all major ions in the spectrum were accounted for.
Data presented as heat-maps (Figures 2 and 3) are from spec-
tral counting, and are means of three technical replicates. While
we considered the possibility unlikely, it is conceivable that non-
phosphorylated peptides would not ionize as well as those that
are phosphorylated, that they might not “fly” as well, or might
in some other way be difficult to compare. To allay any con-
cerns, all the data for detection of both phosphorylated and
non-phosphorylated peptides is presented in the Figures A1–A3.
3D MODELING OF NATIVE A. thaliana PDC E1α AND THE
PHOSPHORYLATION SITE-FLANKING VARIANTS
MUFOLD is an efficient and accurate protein tertiary structure
prediction platform that applies whole and partial template infor-
mation along with computational techniques (Zhang et al., 2010).
For the target, AtPDC E1α, MUFOLD was used first to predict
the secondary structure and solvent accessibility and then to scan
the PDB for target/template alignments. The best templates are
1NI4_A, 2OZL_A, and 3EXE_A from the 1.2.4.1 enzyme family
and 1UMD_A and 2BFF_A from the 1.2.4.4 enzyme family. These
templates cover almost 95% of the target residues. However, the
first 32 N-terminal target residues are either not covered by any
template or the predicted secondary structures (solvent accessi-
bilities) are not matched with the templates. A similar situation
exists for some C-terminal target residues. Thus, MUFOLD was
used to search and evaluate fragmental structures which fit the
target termini in terms of sequence, secondary structure, sol-
vent accessibility, and 3D structure. Finally, MUFOLD used the
structural constraints from templates and fragments to build the
target model. In order to predict the local structure changes
that resulted from each flanking region residue substitution, e.g.,
M293L (peptide 11), the overall process was repeated to build a
3D model.
RESULTS AND DISCUSSION
The E1 component of Type II PDC is an α2β2 heterotetramer.
Mammalian mtPDC is regulated by multi-site phosphoryla-
tion of the E1α subunit, catalyzed by the intrinsic PDK. While
site 1 is preferentially phosphorylated by PDK, saturation phos-
phorylation of any one of the three sites on any single E1α
subunit completely inhibits PDC activity (Sugden and Randle,
1978). The PDK is docked on the inner-lipoyl domain of the
dilipoyl-E2 subunits, and the flexibility of this domain allows
a single kinase to phosphorylate more than one E1α subunit
(Roche et al., 2003). It is believed that phosphorylation at
Ser292 prevents thiamine-PP-induced ordering of the sequence
loop carrying the phosphorylation site. The disordering of this
phosphorylation-loop is caused by a steric clash between the
phosphoryl-group at site 1 and the nearby Ser294, which nulli-
fies a hydrogen-bonding network essential for maintaining the
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loop conformation (Kato et al., 2008). The disordered phos-
phorylation loop impedes binding of lipoyl-domains of the
PDC E2 core to E1, preventing the reductive acetylation step.
This results in disruption of substrate channeling, and leads to
inactivation.
The first site 1 flanking sequence was experimentally deter-
mined by manual Edman sequencing of a tryptic peptide derived
from bovine PDC previously incubated with γ-32P-ATP (Yeaman
et al., 1978; Figures 4A,B). We have chosen to refer to site 1 as
“Ser292,” based upon the sequence of Arabidopsis thaliana E1α
(Luethy et al., 1995). During the genome-sequencing era it has
been established that the position of Ser292 and the sequences
of the flanking amino acids are highly conserved in mtPDC E1α
sequences. When directly studied, it has been verified that Ser292
was phosphorylated by the intrinsic PDK (e.g., Bykova et al., 2003;
Hirani et al., 2011).
Based upon our phylogenic comparisons, the sequences Thr285
to Tyr288, Gly290 to Gly297, and Tyr300 to Arg301 are invariant,
suggesting functional necessity in terms of E1 catalysis, PDK
docking or orientation, or possibly some aspect of phospho-
transfer. Residue 283 is typically large and hydrophobic, although
Thr or Ala is present in some invertebrate sequences (Figure 1).
Residue 284 appears to be unconstrained (Asp, Glu, Val, Ile, Leu,
FIGURE 1 | Relationships among the amino acid sequences
immediately flanking phosphorylation site 1 of mitochondrial PDC
E1α. The un-rooted tree was generated with TreeView version 1.6.6
(http://taxonomy.zoology.gla.ac.uk/rod/treeview.html). Each clade comprises
10 randomly selected sequences. The plant clade includes sequences of
the “tryptic peptide” from Pisum sativum, A. thaliana, Glycine max,
Lycopersicon esculentum, Solanum tuberosum, Beta vulgaris, Medicago
truncatula, Zea mays, Oryza sativa, and Triticum aestivum. The sequences
are identical. The vertebrate clade includes sequences from Homo sapiens,
Rattus norvegicus, Gallus gallus, Macaca fascicularis, Xenopus laevis, Danio
rerio, Oryctolagus cuniculus, Ailuropoda melanoleuca, Heterocephalus
glaber, and Capsaspora owczarzaki. The invertebrate clade includes
sequences from both nematodes and insects; Ascaris suum,
Caenorhabditis elegans, Bombyx mori, Aedes aegypti, Drosophila
melanogaster, Daphnia pulex, Tribolium castaneum, Solenopsis invicta,
Amblyomma maculatum, and Batrachochytrium dendrobatidis. The fungal
clade includes sequences from Saccharomyces cerevisiae,
Schizosaccharomyces pombe, Kluyveromyces lactis, Naumovozyma
dairenensis, Clavispora lusitaniae, Meyerozyma guilliermondii,
Schizophyllum commune, Fusarium oxysporum, Verticillium alboatrum, and
Ajellomyces capsulatus. The clade sequence presentations were
assembled using WebLogo (Crooks et al., 2004).
Gln, Asn, or Ala). Residue 289 is most often Gly or His, but can
also be Ser, Thr, or Phe in the invertebrate sequences. Residue 298
is most often Ser or Thr, but can also be Val, Ile, or Tyr. Residue
299 is Ser in both vertebrate and invertebrate sequences, but Thr
in plants and fungi. The Ser299 residue is regulatory phosphory-
lation site 2 in mammalian PDC (Davis et al., 1977; Sugden et al.,
1979; Mullinax et al., 1985).
Our “scanningmutagenesis” strategy, using synthetic peptides,
recombinant PDK, and the quantitative KiC assay, yielded a set of
results that would have been at least difficult to obtain using site-
directed mutagenesis of the intact protein sequence because of
the occurrence of competing effects upon catalytic activity (e.g.,
Hirani et al., 2011). As suggested by the results from compara-
tive sequence analyses, the site 1 flanking sequences tolerate little
change. Only a few conserved “mutations” at specific positions
allowed fractional activity (Figure 2, and Huang et al., 2010). In
no instance did any peptide yield a hyperactive result. While the
Y288A (peptide 58) is a drastic change, it was unexpected that a
change three residues distal to S292 would have such a large effect
upon phosphorylation (Figure 2). Especially in light of the obser-
vation that the H289A (peptide 54) change had a much smaller
inhibition. “Conservative” substitutions for His289 (Lys, Arg, Asn;
peptides 36–38, respectively) all resulted in a 55% inhibition of
phosphorylation of Ser292 (Figure 2). Changes of Gly290 to Ala
(peptide 33) or Ser (peptide 34) inhibited phosphorylation of
Ser292 much less than did changes to Pro (peptide 32) or Thr
FIGURE 2 | The effects of single amino acid changes to the sequences
flanking phosphorylation site 1 of A. thaliana PDC E1α. Values are
percentage changes compared with the native sequences, and are the
means of three technical replicates.
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(peptide 35). Most changes to His291 (peptides 3–5, 17, 18, 27–31)
completely inhibited phosphorylation, and the S292A (peptide
48) and S292T (59) peptides were not phosphorylated (Figure 2).
It has previously been reported that S292T peptides were not
phosphoryl acceptors (Miernyk and Randall, 1989; Huang et al.,
2010).
We have chosen to present our peptide phosphorylation data
as spectral counts, a relatively simple format that is being increas-
ingly used in proteomic analyses (Mueller et al., 2008; Huang
et al., 2010; Thelen and Miernyk, 2012). While our numbers are
not large, they are reproducible (Figures A1–A3), and it is clear
that there are not any problems detecting and quantifying either
phosphorylated or non-phosphorylated peptides.
Phosphorylation of the M293L (11) peptide was inhibited
50%, but any other changes, conservative or otherwise, com-
pletely prevented phosphorylation of Ser292 (peptides 12–22;
Figure 2, and Huang et al., 2010). The structural bases for the dif-
ferences must be subtle because there do not appear to be any
major perturbations (Figures 4D,E). It was previously reported
that oxidation of Met293 to MetSO almost completely blocked
phosphorylation of Ser292 (Miernyk et al., 2009; Huang et al.,
2010), and it was proposed that this reversible change might be
of regulatory importance.
The S294T substitution (peptide 60) decreased phosphoryla-
tion of Ser292 50%, while changes to Ala (peptide 49) or Gly
(peptide 46) inhibited it completely (Figure 2, and Huang et al.,
2010). It has been proposed that Ser294 might be involved in
thiamin-PP binding (Kato et al., 2008). Our results suggest that it
is the hydroxyl-group that is necessary for phosphorylation rather
than simply spacing due to amino acid size (S/T v. A).
We observed that any changes to Asp295, including the con-
servative D295E (peptide 23) change, resulted in complete inhi-
bition of Ser292 phosphorylation (Figure 2). From the predicted
FIGURE 3 | The effects of multiple simultaneous amino acid changes to
the sequences flanking phosphorylation site 1 of A. thaliana PDC E1α.
Values are percentage changes compared with the native sequences, and
are the means of three technical replicates.
structures, it can be seen that the D295K (Figure 4F) and D295E
(Figure 4G) changes cause significant changes in the position-
ing/presentation of Ser294, Met293, and Ser292. Previous studies
of the D295N change using peptide substrates with the mam-
malian PDK showed substantially reduced phosphorylation of
S292, and it was proposed that Asp295 is involved with PDK bind-
ing (Mullinax et al., 1985). The results of Mullinax et al. (1985)
were recently verified by Hirani et al. (2011) using recombinant
A. thaliana PDC-E1 and PDK. The D295N, D295A, and D295L
site-directed mutants all had greatly reduced phosphorylation
of E1α.
Because of an unfortunate oversight in our experimental
design, we failed to systematically evaluate changes to Pro296. We
believe, however, that the absolute conservation of Pro at this
FIGURE 4 | Predicted local structure of the A. thaliana PDC E1α
subunit, with emphasis on the phosphorylation site 1 (Ser292)-flanking
residues. Panel (A) includes the 3D representation of the full-length E1α
subunit. Regulatory phosphorylation site 1 is shown as a colored
stick-diagram. In panel (B), an enlarged version of the sequence flanking
site 1 is presented. In panels (C–G) the stick-diagrams of selected amino
acid substitution variants are presented. The small inset boxes indicate the
extent of phosphorylation relative to the native sequence.
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position in all E1α sequences (Figure 1), and the complete loss
of phosphorylation resulting from the exchange of Pro296Gly297
for Gly296Pro297 (Figure 3) support our contention that any
change from Pro at position 296 will also result in the loss of
phosphorylation.
When residue 297 was changed from Gly to Pro (peptide 41),
Ala (peptide 43), Ser (peptide 44), or Thr (peptide 45), phos-
phorylation of Ser292 was reduced from 65 to 90% (Figure 2).
Hirani et al. (2011) reported that with the G297S and G297D
site-directed mutants the phosphorylation of Ser292 was only
inhibited approximately 30%. The phylogenetic sequence align-
ments revealed an absolute conservation of Gly at position 297
(Figure 1). As was found with substitutions for the N-terminal
Tyr288, changes to the distal C-terminal Ser298, Thr299, Tyr300, and
Arg301 residues significantly inhibited phosphorylation of Ser292
(30–60%).
While even a single conservative change to a flanking
amino acid might substantially reduce phosphorylation of Ser292
(Figure 2), nearly all multiple-changes completely abolished
phosphorylation (Figure 3 and Table A1). This included the sim-
ple exchanging or scrambling of neighboring residues. The multi-
ple changes probably reflect a combination of reduced accessibil-
ity of Ser292 to PDK plus impaired recognition and/or binding.
The single exception to this among the peptides screened was
the switching of Ser298/Thr299 (peptide 2) which was without
substantial effect on phosphorylation of Ser292 (Figure 3). This
exchange converts the plant flanking-sequence to that of mam-
malian E1α and recreates mammalian site 2 (Figure 1). Despite
this, Ser299 was not phosphorylated in our assays. When the
predicted structure of peptide 2 (Table A1), which contains the
Ser298/Thr299 to Thr298/Ser299 exchange, is examined (Figure 4C)
it can be seen that in addition to other minor changes there is a
significant change in the presentation of D295. While this does not
affect phosphorylation of Ser292, it might contribute to Ser299 not
being phosphorylated. It is additionally noteworthy that all previ-
ous reports of phosphorylation of mammalian site 2 have been
done with either intact PDC or the E2-containing subcomplex
present in the assays along with E1 and PDK.
CONCLUSIONS
Understanding the structure-function relationship between pro-
tein kinases and their clients is integral to understanding
kinase specificity. Herein we demonstrate a facile approach for
comprehensively and quantitatively assessing kinase specificity,
using the MS-based KiC assay. There are two potential concerns
with the use of MS for studying peptide-protein interactions;
accurate discrimination of isobaric peptides, and differential ion-
ization efficiency. To control for these two problems, respectively,
we performed all peptide assays independently, and expressed
phosphorylation efficiency as a ratio to the non-phosphorylated
species. This assumes that phosphorylated peptides ionize with
similar efficiency, which might otherwise be a concern in a more
dramatic mutagenic schema.
The primary sequence drives formation of the secondary
structure that underlies catalysis. In the case of the peptides being
studied, there are primary sequence constraints relative to bind-
ing of both the substrate pyruvate and the co-factor thiamin-PP.
At the same time, the evolutionary acquisition of reversible phos-
phorylation as a regulatory mechanism must have included the
selection of primary sequence requirements necessary for kinase
(and phosphatase) recognition and binding. It is the combina-
tion of these two interacting selective considerations, along with
those related to the catalytic function of E1, that likely comprise
the basis for the stringent primary-sequence specificity including
and flanking “Ser292.”
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APPENDIX
Table A1 | Synthetic peptide-variants of the plant pyruvate
dehydrogenase E1α phosphorylation site 1-flanking sequences.
Number Sequence MW
1 YHGHSMSDPGSTYR 1594.6703
2 YHGHSMSDPGTSYR 1594.6703
3 YHGSHMSDPGSTYR 1594.6703
4 YHSGHMSDPGSTYR 1594.6703
5 YSHGHMSDPGSTYR 1594.6703
6 YHGHMSSDPGSTYR 1594.6703
7 YHGHMSDSPGSTYR 1594.6703
8 YHGHMSDPSGSTYR 1594.6703
9 YHGHMSDPGSSTYR 1594.6703
10 YHGHMSDPGSTSYR 1594.6703
11 YHGHSLSDPGSTYR 1576.7139
12 YHGHSISDPGSTYR 1576.7139
13 YHGHSVSDPGSTYR 1562.6982
14 YHGHSFSDPGSTYR 1610.6982
15 YHGHSYSDPGSTYR 1626.6931
16 YHGHSWSDPGSTYR 1649.7091
17 YHGMHSSDPGSTYR 1594.6703
18 YHMGHSSDPGSTYR 1594.6703
19 YHGHSSMDPGSTYR 1594.6703
20 YHGHSSDMPGSTYR 1594.6703
21 YHGHSSDPMGSTYR 1594.6703
22 YHGHSSDPGMSTYR 1594.6703
23 YHGHSMSEPGSTYR 1608.6859
24 YHGHSMSKPGSTYR 1607.7383
25 YHGHSMSRPGSTYR 1635.7445
26 YHGHSMSNPGSTYR 1593.6863
27 YHGKSMSDPGSTYR 1585.7063
28 YHGRSMSDPGSTYR 1613.7125
29 YHGNSMSDPGSTYR 1571.6543
30 YHGDSMSDPGSTYR 1572.6383
31 YHGESMSDPGSTYR 1586.6540
32 YHPHSMSDPGSTYR 1634.7016
33 YHAHSMSDPGSTYR 1608.6859
34 YHSHSMSDPGSTYR 1624.6809
35 YHTHSMSDPGSTYR 1638.6965
36 YKGHSMSDPGSTYR 1585.7063
37 YRGHSMSDPGSTYR 1613.7125
38 YNGHSMSDPGSTYR 1571.6543
39 YDGHSMSDPGSTYR 1572.6383
40 YEGHSMSDPGSTYR 1586.6540
41 YHGHSMSDGPSTYR 1594.6703
42 YHGHSMSDPPSTYR 1634.7016
43 YHGHSMSDPASTYR 1608.6859
44 YHGHSMSDPSSTYR 1624.6809
(Continued)
Table A1 | Continued.
Number Sequence MW
45 YHGHSMSDPTSTYR 1638.6965
46 YHGHSMGDPGSTYR 1564.6597
47 YHGHSMSDPGSTSR 1518.6390
48 YHGHAMSDPGSTYR 1578.6754
49 YHGHSMADPGSTYR 1578.6754
50 YHGHSASDPGSTYR 1534.6669
51 YHGHSQSDPGSTYR 1591.6884
52 YHGHSMSAPGSTYR 1550.6805
53 YHGHSMSDPGATYR 1578.6754
54 YAGHSMSDPGSTYR 1528.6485
55 YHGASMSDPGSTYR 1528.6485
56 YHGHSMSDPGSTAR 1502.6441
57 YHGHSMSDPGSAYR 1564.6597
58 AHGHSMSDPGSTYR 1502.6441
59 YHGHTMSDPGSTYR 1608.6859
60 YHGHSMTDPGSTYR 1608.6859
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FIGURE A1 | The effects of changes to the amino acids
flanking phosphorylation site 1 of A. thaliana PDH E1α.
(A,B) indicate double and multiple changes, respectively. Bold
underlined letters in the amino acid sequence indicates the
sites of change. A lower case letter indicates a potential phosphorylation
site. The spectral count data presented are means of three technical
replicates each for both phosphorylated and non-phosphorylated
peptides.
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FIGURE A2 | The effects of single changes to (A) His289/His291, or (B) Met293. The spectral count data presented are means of three technical
replicates each for both phosphorylated and non-phosphorylated peptides.
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FIGURE A3 | The effects of single changes to the amino acid residues flanking phosphorylation site 1 of A. thaliana PDH E1α. The spectral count data
presented are means of three technical replicates each for both phosphorylated and non-phosphorylated peptides.
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